98.01 USD
+0.55 (+0.56%)
98.02 USD
+0.01 (+0.01%)
ChartMill assigns a Buy % Consensus number of 83% to NDAQ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 109.06. This target is 11.28% above the current price.
NDAQ was analyzed by 24 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NDAQ.
In the previous month the buy percentage consensus was at a similar level.
NDAQ was analyzed by 24 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-20 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-10-22 | TD Cowen | Maintains | Hold -> Hold |
| 2025-10-22 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-13 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-08 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-01 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-04 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-25 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-07-25 | UBS | Upgrade | Neutral -> Buy |
| 2025-07-25 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-07-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-25 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-10 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-10 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-09 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-06-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-25 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-04-25 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-25 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-10 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-04-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-08 | Citigroup | Maintains | Neutral -> Neutral |
NASDAQ INC / NDAQ FAQ
What is the price target for NDAQ stock?
24 analysts have analysed NDAQ and the average price target is 109.06 USD. This implies a price increase of 11.28% is expected in the next year compared to the current price of 98.01.
What is the consensus rating for NDAQ stock?
The consensus rating for NASDAQ INC (NDAQ) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NASDAQ INC (NDAQ) stock?
The number of analysts covering NASDAQ INC (NDAQ) is 24.